Financials
- Market Capitalization 23.77 M
- Employee 40
- Founded 2015
- CEO N/A
- Website www.nextcure.com
- Headquarter Delaware, United States
- FIGI BBG00BTH5153
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4537 | BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.61 USD | 0.00% | -1.61% | -12.86% | -40.20% | 24.92 M USD | ||
| 4548 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.44 USD | -1.37% | -13.77% | +6.67% | -8.28% | 24.01 M USD | ||
| 4551 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.73 USD | 0.00% | +7.35% | +5.80% | -64.73% | 23.77 M USD | ||
| 4553 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +9.23% | +16.39% | -46.21% | 23.68 M USD |
Frequently asked questions about NextCure, Inc. - Common Stock
What is the NextCure, Inc. - Common Stock stock price today?
The current price of NextCure, Inc. - Common Stock (NXTC) is 6.58. Over the past 24 hours, the stock has changed by +201.83%. Follow the NXTC chart for real-time price dynamics.
What is the stock ticker of NextCure, Inc. - Common Stock?
NextCure, Inc. - Common Stock trades under the ticker NXTC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NextCure, Inc. - Common Stock stock going up?
NXTC has changed by +239.18% over the last week, +219.42% over the last month, and -49.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was NextCure, Inc. - Common Stock net income for the last quarter?
NextCure, Inc. - Common Stock reported net income of -9.8 M for the last quarter. The previous quarter showed -9.44 M, which means net income changed by -3.82%.
How many employees does NextCure, Inc. - Common Stock have?
As of the latest available data, NextCure, Inc. - Common Stock has 40 employees. Workforce size can provide additional context about the company's scale and operations.
What is NextCure, Inc. - Common Stock EBITDA?
NextCure, Inc. - Common Stock EBITDA is -10.16 M, and its EBITDA margin is -508.1 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NextCure, Inc. - Common Stock stock?
You can buy NextCure, Inc. - Common Stock (NXTC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NextCure, Inc. - Common Stock stock?
Investing in NextCure, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NXTC chart and related analysis on metatrader.com as part of your research.